Please assess the completion status of the following clinical trial:

Trial Title: A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients 18-65 years of age;~* previously untreated indolent nonfollicular non-Hodgkin's lymphoma;~* active disease;~* \>=3 involved sites.~Exclusion Criteria:~* typical chronic lymphocytic leukemia;~* other malignancies within 3 years before study, except basal or squamous cell skin cancer or cancer in situ of the cervix;~* systemic corticosteroid use for \>1 month;~* significant cardiovascular disease;~* central nervous system involvement;~* hepatitis B or C virus infection, or HIV infection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).